NZ195354A - Pharmaceutical compositions containing lipid amines formulated with fat or lipid emulsions - Google Patents

Pharmaceutical compositions containing lipid amines formulated with fat or lipid emulsions

Info

Publication number
NZ195354A
NZ195354A NZ195354A NZ19535480A NZ195354A NZ 195354 A NZ195354 A NZ 195354A NZ 195354 A NZ195354 A NZ 195354A NZ 19535480 A NZ19535480 A NZ 19535480A NZ 195354 A NZ195354 A NZ 195354A
Authority
NZ
New Zealand
Prior art keywords
lipid
fat
pharmaceutical compositions
compositions containing
emulsions
Prior art date
Application number
NZ195354A
Other languages
English (en)
Inventor
J Wolff Iii
G Hemsworth
K Jensen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ195354A publication Critical patent/NZ195354A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ195354A 1979-10-26 1980-10-23 Pharmaceutical compositions containing lipid amines formulated with fat or lipid emulsions NZ195354A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/088,638 US4310550A (en) 1979-10-26 1979-10-26 Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants

Publications (1)

Publication Number Publication Date
NZ195354A true NZ195354A (en) 1982-12-21

Family

ID=22212534

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ195354A NZ195354A (en) 1979-10-26 1980-10-23 Pharmaceutical compositions containing lipid amines formulated with fat or lipid emulsions

Country Status (7)

Country Link
US (1) US4310550A (enExample)
JP (1) JPS5671024A (enExample)
AU (1) AU522338B2 (enExample)
CA (1) CA1163562A (enExample)
DE (1) DE2945788A1 (enExample)
NZ (1) NZ195354A (enExample)
PT (1) PT71236A (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058021A3 (en) * 1981-02-06 1982-10-27 Beecham Group Plc Pharmaceutical compositions
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
NL9000207A (enExample) * 1990-01-29 1991-08-16 Duphar Int Res
US6369201B1 (en) 1998-02-19 2002-04-09 Metamorphix International, Inc. Myostatin multimers
EP2295075A1 (en) 2001-01-04 2011-03-16 University Of Saskatchewan Enterohemorragic escherichia coli vaccine
BRPI0415816A (pt) 2003-10-31 2006-12-26 Univ British Columbia composição, bactéria ou um preparado da mesma, método para detectar a presença de um patógeno de a/e em uma amostra, método para provocar uma resposta imunológica contra um patógeno de a/e ou um componente do mesmo em um animal, método para reduzir a colonização de um patógeno de a/e em um animal, método para reduzir a disseminação de um patógeno de a/e em um animal, método para o tratamento ou a prevenção da infecção por um patógeno de a/e, método para atenuar a virulência de um patógeno de a/e, método para a seleção de um composto que atenue a virulência de um patógeno e a/e, método para a produção de um polipeptìdio de patógeno de a/e, polipeptìdio recombinante, molécula de ácido nucléico isolada, vetor, célula hospedeira, uso da composição e kit
PT1742659E (pt) * 2004-04-05 2013-06-03 Pah Usa 15 Llc Emulsões de óleo em água microfluidizadas e composições de vacinas
US20080102067A1 (en) * 2006-10-25 2008-05-01 Cook Mark E Immunogenic composition
WO2017011919A1 (en) 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma vaccines and uses thereof
MX2022013152A (es) 2020-04-20 2023-02-09 Univ Saskatchewan Composiciones y métodos para prevenir, controlar y diagnosticar infecciones por micobacterias.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
US3872171A (en) * 1971-05-24 1975-03-18 Pfizer Polyamines as antiviral agents in animals
US4034040A (en) * 1971-05-24 1977-07-05 Pfizer Inc. Xylene-diamines as antiviral agents
US4173641A (en) * 1978-05-15 1979-11-06 Pfizer Inc. Di-O-n-alkyl glycerol derivatives as immune stimulants

Also Published As

Publication number Publication date
AU522338B2 (en) 1982-05-27
DE2945788A1 (de) 1981-05-07
US4310550A (en) 1982-01-12
JPS5671024A (en) 1981-06-13
AU6366480A (en) 1981-04-30
JPS6225646B2 (enExample) 1987-06-04
PT71236A (en) 1980-06-01
DE2945788C2 (enExample) 1988-01-28
CA1163562A (en) 1984-03-13

Similar Documents

Publication Publication Date Title
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
ZA804853B (en) Lubricating compositions
AR230178A1 (es) Procedimiento para preparar composiciones farmaceuticas
GB2051788B (en) 3 - thiovinyl - cephalosporins their preparation and compositions containing them
IT1194595B (it) Formulazioni solide contenenti ferormoni
IL59615A0 (en) Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives and pharmaceutical compositions containing them
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
GB2066493B (en) Liquid developer compositions
EG14220A (en) Oil-in-water insecticidal compositions
NZ195354A (en) Pharmaceutical compositions containing lipid amines formulated with fat or lipid emulsions
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
ZA805666B (en) Pharmaceutical compositions containing paracetamol
NZ194348A (en) Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
IL60731A0 (en) Pharmaceutical compositions comprising propranolol
IL61117A (en) 2beta-acetoxymethyl-penam compounds and pharmaceutical compositions containing them
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
IL60600A (en) Pharmaceutical compositions comprising certain azolylalkenol compounds
IL60198A0 (en) Pharmaceutical compositions containing alcohols
IL60695A0 (en) Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them
IL60332A0 (en) Pyridylaminotriazole derivatives and pharmaceutical compositions containing them
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them